TC
XERS icon

Truvestments Capital’s Xeris Biopharma Holdings XERS Stock Holding History

Truvestments Capital’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.1K Buy
8,978
+860
+11% +$5.49K 0.01% 470
2026
Q1 		$47.1K Hold
8,118
– – 0.01% 510
2025
Q4 		$63.7K Buy
8,118
+3,979
+96% +$31.3K 0.01% 410
2025
Q3 		$33.7K Buy
4,139
+566
+16% +$3.76K 0.01% 498
2025
Q2 		$16.7K Buy
+3,573
New +$16.4K ﹤0.01% 567
2025
Q1 		– Sell
-847
Closed -$2.87K – 1165
2024
Q4 		$2.87K Buy
+847
New +$2.72K ﹤0.01% 779

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Truvestments Capital's XERS Position: Q2 2026 in Review

Truvestments Capital increased its Xeris Biopharma Holdings (XERS) stake by 11% in Q2 2026, buying an estimated $5.49K and bringing the position to 8,978 shares worth $71.1K. The position accounts for 0.01% of the portfolio, ranked #470.

Truvestments Capital first reported a position in XERS in Q4 2024 and has held it in 6 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Truvestments Capital held 8,978 shares of Xeris Biopharma Holdings worth $71.1K as of Q2 2026.
  • Truvestments Capital bought 860 Xeris Biopharma Holdings shares in Q2 2026, an estimated $5.49K.
  • Xeris Biopharma Holdings made up 0.01% of Truvestments Capital's portfolio in Q2 2026, its #470 holding.
  • Truvestments Capital first reported a position in Xeris Biopharma Holdings in Q4 2024 and has held it in 6 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.